AKAM Form 144: 3,000 Shares from Restricted Stock to Be Sold

Rhea-AI Filing Summary

Akamai Technologies, Inc. (AKAM) Form 144 shows a proposed sale of 3,000 common shares through Charles Schwab & Co., with an aggregate market value of $231,000 and an approximate sale date of 08/22/2025. The filing reports total shares outstanding of 143,385,528. The 3,000 shares to be sold were acquired through restricted stock lapses on 02/21/2025 (220 shares), 03/04/2025 (1,725 shares), and 03/06/2025 (1,055 shares), and payment was made as equity compensation. The filing also discloses a separate sale during the past three months: 3,254 shares sold by Robert Blumofe on 06/12/2025 for gross proceeds of $253,714. The notice includes the standard insider representation regarding material nonpublic information.

Positive

• Securities to be sold were acquired via equity compensation (restricted stock lapses), indicating routine post-vesting liquidity
• Filing specifies broker, share count, and approximate date, fulfilling Rule 144 disclosure requirements

Negative

• Insider sale activity was recently completed (3,254 shares on 06/12/2025), which could be perceived negatively by some investors

Insights

Securities Analyst

TL;DR: Small insider sale from recent restricted stock vesting; not likely material to Akamai’s market capitalization.

The filing documents a proposed disposition of 3,000 shares derived from recent restricted stock lapses, with proceeds estimated at $231,000. Given reported shares outstanding of 143,385,528, the size of this proposed sale is immaterial relative to the company’s market equity. The disclosure is routine for executives or employees monetizing vested equity and includes the required attestation about material nonpublic information. Recent related sale of 3,254 shares for $253,714 indicates prior insider liquidity activity but does not, by itself, convey operational or financial changes.

Corporate Governance Expert

TL;DR: Transaction appears to be post-vesting liquidity under standard insider procedures; disclosure meets Rule 144 requirements.

The schedule shows all securities to be sold originated from restricted stock lapses and were paid as equity compensation, consistent with typical post-vesting sales by insiders or beneficiaries. The filer names the broker and provides the approximate sale date, satisfying procedural transparency. The included past three-month sale by an identified individual provides helpful context for recent insider activity. No statements in the filing indicate any material undisclosed information.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	3000	231000.00	143385528	08/22/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/21/2025	Restricted Stock Lapse	Akamai Technologies, Inc.			220	02/21/2025	Equity Compensation
Common	03/04/2025	Restricted Stock Lapse	Akamai Technologies, Inc.			1725	03/04/2025	Equity Compensation
Common	03/06/2025	Restricted Stock Lapse	Akamai Technologies, Inc.			1055	03/06/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robert Blumofe 145 BROADWAY CAMBRIDGE MA 02142	AKAMAI TECHNOLOGIES INC	06/12/2025	3254	253714.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Akamai's (AKAM) Form 144 disclose about the proposed sale?

The filing reports a proposed sale of 3,000 common shares via Charles Schwab with aggregate market value of $231,000 and approximate sale date 08/22/2025.

Where did the 3,000 shares being sold come from?

All 3,000 shares were acquired through restricted stock lapses on 02/21/2025 (220), 03/04/2025 (1,725), and 03/06/2025 (1,055), paid as equity compensation.

How large is the proposed sale relative to Akamai's outstanding shares?

The filing lists 143,385,528 shares outstanding; the 3,000-share proposed sale is immaterial relative to that total.

Were there any recent related insider sales reported?

Yes. The filing shows Robert Blumofe sold 3,254 shares on 06/12/2025 for gross proceeds of $253,714.

Does the filing indicate any undisclosed material information?

No. The filer makes the required representation that they do not know any material adverse information not publicly disclosed.